2013Laboratory Medicine and ClinicRequires access

Clinical distribution and drug resistance of 228 strains of Pseudomonas aeruginosa

Wang Sang

Open publisher page 0 citations

Abstract

Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa(PAE) to provide references for rational usage of antibiotics in clinic.Methods The characteristics of clinical distribution and drug resistance of 228 strains of PAE,isolated from May.2010 to Dec.2011 in this hospital,were retrospectively analyzed.Results Among 228 PAE isolates,most were collected from Respiratory Department,ICU and Department of Cerebral Surgery,accounting for 36.9%,27.2% and 23.2%.165 strains were isolated from sputum,accounting for 72.4%.The drug resistance rates of PAE to cefoperazone/sulbactam,imipenem,meropenem and amikacin were 0.0%,8.9%,9.6% and 8.3% respectively,to ampicillin,cefazolin and cefotaxime were higher than 67.0% and to ceftazidime,cefepime and piperacillin/tazobactam were lower than 30.0%.Conclusion The drug resistance of PAE might be serious.It should be strengthened to reinforce the monitoring on drug resistance and to standardize the application of antibacterials.

About this research paper

What this paper is about

Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa(PAE) to provide references for rational usage of antibiotics in clinic.Methods The characteristics of clinical distribution and drug resistance of 228 strains of PAE,isolated from May.2010 to Dec.2011 in this hospital,were retrospectively analyzed.Results Among 228 PAE isolates,most were collected from Respiratory Department,ICU and Department of Cerebral Surgery,accounting for 36.9%,27.2% and 23.2%.165 strains were isolated from sputum,accounting for 72.4%.The drug resistance rates of PAE to cefoperazone/sulbactam,imipenem,meropenem and amikacin were 0.0%,8.9%,9.6% and 8.3% respectively,to ampicillin,cefazolin and cefotaxime were higher than 67.0% and to ceftazidime,cefepime and piperacillin/tazobactam were lower than 30.0%.Conclusion The drug resistance of PAE might be serious.It should be strengthened to reinforce the monitoring on drug resistance and to standardize the application of antibacterials.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa(PAE) to provide references for rational usage of antibiotics in clinic.Methods The characteristics of clinical distribution and drug resistance of 228 strains of PAE,isolated from May.2010 to Dec.2011 in this hospital,were retrospectively analyzed.Results Among 228 PAE isolates,most were collected from Respiratory Department,ICU and Department of Cerebral Surgery,accounting for 36.9%,27.2% and 23.2%.165 strains were isolated from sputum,accounting for 72.4%.The drug resistance rates of PAE to cefoperazone/sulbactam,imipenem,meropenem and amikacin were 0.0%,8.9%,9.6% and 8.3% respectively,to ampicillin,cefazolin and cefotaxime were higher than 67.0% and to ceftazidime,cefepime and piperacillin/tazobactam were lower than 30.0%.Conclusion The drug resistance of PAE might be serious.It should be strengthened to reinforce the monitoring on drug resistance and to standardize the application of antibacterials.

Key concepts: Sulbactam, Cefepime, Cefoperazone, Medicine, Cefazolin, Piperacillin, Meropenem, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical distribution and drug resistance of 228 strains of Pseudomonas aeruginosa — Research Paper | ScholarLens